Latest filing published 15 Jun 2021 for PLx Pharma Inc., €12k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Michael J. Valentino span 2 companies, the busiest being Adams Respiratory Therapeutics, Inc. and PLx Pharma Inc. Between 3 April 2006 and 14 June 2021, the trades on record add up to 286 filings.
The open-market side counts 13 purchases for €1.5M alongside 251 sales for €17.7M. On balance, insiders were net sellers of €16.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 18 option exercises. 2021 to date brings 10 purchases and no sales.
Half of the purchases are above €6,172 and half below. 1 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 15 June 2021, reports an open-market purchase of €1,030 in PLx Pharma Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration